179 related articles for article (PubMed ID: 28406315)
1. Selective boron delivery by intra-arterial injection of BSH-WOW emulsion in hepatic cancer model for neutron capture therapy.
Yanagie H; Dewi N; Higashi S; Ikushima I; Seguchi K; Mizumachi R; Murata Y; Morishita Y; Shinohara A; Mikado S; Yasuda N; Fujihara M; Sakurai Y; Mouri K; Yanagawa M; Iizuka T; Suzuki M; Sakurai Y; Masunaga SI; Tanaka H; Matsukawa T; Yokoyama K; Fujino T; Ogura K; Nonaka Y; Sugiyama H; Kajiyama T; Yui S; Nishimura R; Ono K; Takamoto S; Nakajima J; Ono M; Eriguchi M; Hasumi K; Takahashi H
Br J Radiol; 2017 Jun; 90(1074):20170004. PubMed ID: 28406315
[TBL] [Abstract][Full Text] [Related]
2. Feasibility evaluation of neutron capture therapy for hepatocellular carcinoma using selective enhancement of boron accumulation in tumour with intra-arterial administration of boron-entrapped water-in-oil-in-water emulsion.
Yanagie H; Kumada H; Nakamura T; Higashi S; Ikushima I; Morishita Y; Shinohara A; Fijihara M; Suzuki M; Sakurai Y; Sugiyama H; Kajiyama T; Nishimura R; Ono K; Nakajima J; Ono M; Eriguchi M; Takahashi H
Appl Radiat Isot; 2011 Dec; 69(12):1854-7. PubMed ID: 21752660
[TBL] [Abstract][Full Text] [Related]
3. Pilot clinical study of boron neutron capture therapy for recurrent hepatic cancer involving the intra-arterial injection of a (10)BSH-containing WOW emulsion.
Yanagie H; Higashi S; Seguchi K; Ikushima I; Fujihara M; Nonaka Y; Oyama K; Maruyama S; Hatae R; Suzuki M; Masunaga S; Kinashi T; Sakurai Y; Tanaka H; Kondo N; Narabayashi M; Kajiyama T; Maruhashi A; Ono K; Nakajima J; Ono M; Takahashi H; Eriguchi M
Appl Radiat Isot; 2014 Jun; 88():32-7. PubMed ID: 24559940
[TBL] [Abstract][Full Text] [Related]
4. Single-dose toxicity study by intra-arterial injection of
Yanagie H; Yanagawa M; Higuchi T; Mizumachi R; Fujihara M; Morishita Y; Sakurai Y; Mouri K; Dewi N; Nonaka Y; Shinohara A; Matsukawa T; Kubota A; Yokoyama K; Suzuki M; Masunaga SI; Sakurai Y; Tanaka H; Ono K; Yamauchi H; Ono M; Nakajima J; Higashi S; Takahashi H
Appl Radiat Isot; 2020 Sep; 163():109202. PubMed ID: 32561043
[TBL] [Abstract][Full Text] [Related]
5. Suppression of Tumor Growth in a Rabbit Hepatic Cancer Model by Boron Neutron Capture Therapy With Liposomal Boron Delivery Systems.
Yanagie H; Yanagawa M; Morishita Y; Shinohara A; Dewi N; Nonaka Y; Furuya Y; Mizumachi R; Murata Y; Nakamura H; Suzuki M; Sakurai Y; Tanaka H; Masunaga S; Ono K; Sugihara T; Nashimoto M; Yamauchi H; Ono M; Nakajima J; Takahashi H
In Vivo; 2021; 35(6):3125-3135. PubMed ID: 34697143
[TBL] [Abstract][Full Text] [Related]
6. Intra-arterial administration of sodium borocaptate (BSH)/lipiodol emulsion delivers B-10 to liver tumors highly selectively for boron neutron capture therapy: experimental studies in the rat liver model.
Suzuki M; Masunaga S; Kinashi Y; Nagata K; Sakurai Y; Nakamatsu K; Nishimura Y; Maruhashi A; Ono K
Int J Radiat Oncol Biol Phys; 2004 May; 59(1):260-6. PubMed ID: 15093923
[TBL] [Abstract][Full Text] [Related]
7. Dosimetric study of boron neutron capture therapy with borocaptate sodium (BSH)/lipiodol emulsion (BSH/lipiodol-BNCT) for treatment of multiple liver tumors.
Suzuki M; Sakurai Y; Masunaga S; Kinashi Y; Nagata K; Ono K
Int J Radiat Oncol Biol Phys; 2004 Mar; 58(3):892-6. PubMed ID: 14967447
[TBL] [Abstract][Full Text] [Related]
8. Suitability of boron carriers for BNCT: accumulation of boron in malignant and normal liver cells after treatment with BPA, BSH and BA.
Chou FI; Chung HP; Liu HM; Chi CW; Lui WY
Appl Radiat Isot; 2009 Jul; 67(7-8 Suppl):S105-8. PubMed ID: 19375330
[TBL] [Abstract][Full Text] [Related]
9. Tumor Growth Suppression With Novel Intra-arterial Chemotherapy Using Epirubicin-entrapped Water-in-oil-in-water Emulsion
Yanagie H; Fujino T; Yanagawa M; Terao T; Imagawa T; Fujihara M; Morishita Y; Mizumachi R; Murata Y; Dewi N; Ono Y; Ikushima I; Seguchi K; Nagata M; Nonaka Y; Furuya Y; Hisa T; Nagasaki T; Arimori K; Nakashima T; Sugihara T; Kakimi K; Ono M; Nakajima J; Eriguchi M; Higashi S; Takahashi H
In Vivo; 2021; 35(1):239-248. PubMed ID: 33402470
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of a novel sodium borocaptate-containing unnatural amino acid as a boron delivery agent for neutron capture therapy of the F98 rat glioma.
Futamura G; Kawabata S; Nonoguchi N; Hiramatsu R; Toho T; Tanaka H; Masunaga SI; Hattori Y; Kirihata M; Ono K; Kuroiwa T; Miyatake SI
Radiat Oncol; 2017 Jan; 12(1):26. PubMed ID: 28114947
[TBL] [Abstract][Full Text] [Related]
11. Biodistribution of 10B in a rat liver tumor model following intra-arterial administration of sodium borocaptate (BSH)/degradable starch microspheres (DSM) emulsion.
Suzuki M; Nagata K; Masunaga S; Kinashi Y; Sakurai Y; Maruhashi A; Ono K
Appl Radiat Isot; 2004 Nov; 61(5):933-7. PubMed ID: 15308171
[TBL] [Abstract][Full Text] [Related]
12. Therapeutic efficacy for hepatocellular carcinoma by boric acid-mediated boron neutron capture therapy in a rat model.
Lin SY; Lin CJ; Liao JW; Peir JJ; Chen WL; Chi CW; Lin YC; Liu YM; Chou FI
Anticancer Res; 2013 Nov; 33(11):4799-809. PubMed ID: 24222116
[TBL] [Abstract][Full Text] [Related]
13. Combination of the vascular targeting agent ZD6126 with boron neutron capture therapy.
Masunaga S; Sakurai Y; Suzuki M; Nagata K; Maruhashi A; Kinash Y; Ono K
Int J Radiat Oncol Biol Phys; 2004 Nov; 60(3):920-7. PubMed ID: 15465210
[TBL] [Abstract][Full Text] [Related]
14. Intracellular targeting of sodium mercaptoundecahydrododecaborate (BSH) to solid tumors by transferrin-PEG liposomes, for boron neutron-capture therapy (BNCT).
Maruyama K; Ishida O; Kasaoka S; Takizawa T; Utoguchi N; Shinohara A; Chiba M; Kobayashi H; Eriguchi M; Yanagie H
J Control Release; 2004 Aug; 98(2):195-207. PubMed ID: 15262412
[TBL] [Abstract][Full Text] [Related]
15. The usefulness of mild temperature hyperthermia combined with a newly developed hypoxia-oriented 10B conjugate compound, TX-2100, for boron neutron capture therapy.
Masunaga S; Nagasawa H; Sakurai Y; Uto Y; Hori H; Nagata K; Suzuki M; Maruhashi A; Kinashi Y; Ono K
Int J Hyperthermia; 2006 Jun; 22(4):287-99. PubMed ID: 16754350
[TBL] [Abstract][Full Text] [Related]
16. Synthesis and Evaluation of Dodecaboranethiol Containing Kojic Acid (KA-BSH) as a Novel Agent for Boron Neutron Capture Therapy.
Takeuchi K; Hattori Y; Kawabata S; Futamura G; Hiramatsu R; Wanibuchi M; Tanaka H; Masunaga SI; Ono K; Miyatake SI; Kirihata M
Cells; 2020 Jun; 9(6):. PubMed ID: 32630612
[TBL] [Abstract][Full Text] [Related]
17. Effect of electroporation on cell killing by boron neutron capture therapy using borocaptate sodium (10B-BSH).
Ono K; Kinashi Y; Masunaga S; Suzuki M; Takagaki M
Jpn J Cancer Res; 1998 Dec; 89(12):1352-7. PubMed ID: 10081497
[TBL] [Abstract][Full Text] [Related]
18. Applicability of the 2-nitroimidazole-sodium borocaptate-10B conjugate, TX-2060, as a 10B-carrier in boron neutron capture therapy.
Masunaga S; Nagasawa H; Hiraoka M; Sakurai Y; Uto Y; Hori H; Nagata K; Suzuki M; Maruhashi A; Kinashi Y; Ono K
Anticancer Res; 2004; 24(5A):2975-83. PubMed ID: 15517904
[TBL] [Abstract][Full Text] [Related]
19. Changed delivery of boron to tumours using electroporation for boron neutron capture therapy with BSH.
Cemazar M; Skrk J; Mitrovic B; Sersa G
Br J Radiol; 2000 Feb; 73(866):195-200. PubMed ID: 10884734
[TBL] [Abstract][Full Text] [Related]
20. Application of drug delivery system to boron neutron capture therapy for cancer.
Yanagië H; Ogata A; Sugiyama H; Eriguchi M; Takamoto S; Takahashi H
Expert Opin Drug Deliv; 2008 Apr; 5(4):427-43. PubMed ID: 18426384
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
